Research News

Research funding comparison: AMRC vs UK Government

Friday, 15 April 2016 14:34

The Association of Medical Research Charities (AMRC) has conducted an analysis comparing charitable and government funding across the medical research landscape. The analysis delves into how the £1.3bn AMRC members invest in research annually is spent and how this compares to government-funded research.

Media coverage of health and medical science

Friday, 15 April 2016 14:29

The Academy of Medical Sciences (AMS) is undertaking a project that asks ‘How can we all best use evidence to judge the potential benefits and harms of medicines?’ ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it , Director of Communications at AMS, has more details). As part of this wider project, they are interested in hearing people’s views on communicating evidence – how the public understands science and public health research. One strand of this communicating-evidence project is media coverage of health and medical science – how it is communicated from scientists to the public via the media; how much the public understand about different types of evidence and what they ought or ought not to take from it. If you are interested in taking part, you can fill out an online survey.

Launch of the UKCRC Tissue Directory

Friday, 15 April 2016 14:26

The UKCRC Tissue Directory 1.0 is now open to allow researchers and organisations who are custodians of samples to register their collections. This resource aims to become the focal point for all biobanking activity in the UK.

Progress being made with UK clinical trials metrics

Monday, 11 April 2016 15:21

This report on UK Clinical Trials has been sent out to UKTI and FCO/BIS Science & Innovation Network colleagues by Professor Chris Whitty, Chief Scientific Advisor at the Department of Health. This follows the previous report sent out in March 2015 by Dame Sally Davies. The report presents data from a variety of sources showing that the UK is increasing its volume of research, patient recruitment, speed of study set up and European competitiveness.

Page 8 of 15